Trademark: NUTCRACKER 2200002
Word
NUTCRACKER
Device Descrption:
NUTCRACKER,STYLISED IS LTR A, NUTCRACKER,STYLISED WITH MOLECULAR-DIAGRAM IS LTR A
ID
2200002
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
17 March 2021
Registration Date
17 March 2021
Renewal Date
17 March 2031
Owner(s)
Service
Pizzeys Patent and Trade Mark Attorneys Pty Ltd
Goods and Services:
Class 1:
Active chemical ingredients, including m-RNA, for use in the manufacture of anti-cancer drugs; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with transcription and translation of nucleic acid; chemical solutions and preparations consisting of pre-mixed reactants and reagents used to transfect nucleic acid into cells in the field of scientific research; active chemical ingredients for use in manufacture of anti-cancer drugs; protein arrays and nucleotide arrays for scientific use; nucleic acids, proteins and peptides for laboratory use; diagnostic preparations for scientific or research use other than for medical purposes; macromolecules, namely, nucleic acid sequences and proteins, used for pharmaceutical manufacturing and scientific purposes.
Active chemical ingredients, including m-RNA, for use in the manufacture of anti-cancer drugs; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with transcription and translation of nucleic acid; chemical solutions and preparations consisting of pre-mixed reactants and reagents used to transfect nucleic acid into cells in the field of scientific research; active chemical ingredients for use in manufacture of anti-cancer drugs; protein arrays and nucleotide arrays for scientific use; nucleic acids, proteins and peptides for laboratory use; diagnostic preparations for scientific or research use other than for medical purposes; macromolecules, namely, nucleic acid sequences and proteins, used for pharmaceutical manufacturing and scientific purposes.
Class 5:
Macromolecules, namely, nucleic acid sequences and proteins, used for medical purposes; nucleic acid sequences and chemical reagents for medical purposes; protein arrays and nucleotide arrays for medical laboratory use; diagnostic preparations for clinical or medical laboratory use.
Macromolecules, namely, nucleic acid sequences and proteins, used for medical purposes; nucleic acid sequences and chemical reagents for medical purposes; protein arrays and nucleotide arrays for medical laboratory use; diagnostic preparations for clinical or medical laboratory use.
Class 9:
Cartridges and DNA chips to receive and preserve biological samples for use in RNA transcription; scientific apparatus and instruments for manufacturing m-RNA and parts and fittings therefore; laboratory apparatus and instruments for transcription of RNA from DNA and translation to m-RNA; scientific apparatus for receiving DNA samples, transcribing RNA, and producing m-RNA molecules for use in identifying and/or manufacturing therapeutic drugs to treat human diseases.
Cartridges and DNA chips to receive and preserve biological samples for use in RNA transcription; scientific apparatus and instruments for manufacturing m-RNA and parts and fittings therefore; laboratory apparatus and instruments for transcription of RNA from DNA and translation to m-RNA; scientific apparatus for receiving DNA samples, transcribing RNA, and producing m-RNA molecules for use in identifying and/or manufacturing therapeutic drugs to treat human diseases.
Class 35:
Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; compiling data for research purposes in the field of medical science and medical consultancy.
Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; compiling data for research purposes in the field of medical science and medical consultancy.
Class 42:
Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic sciences; DNA analysis services for scientific research purposes; medical and scientific research, in particular in the fields of prevention and treatment cancer; providing scientific research information, consultancy, and advisory services, in particular in the fields of prevention and treatment of cancer treatment; conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; and consulting services for others in the field of design, planning, and implementation of clinical trials; design, engineering, research, development and testing services in the field of nucleic acid sciences for medical, scientific and technological applications; scientific research; scientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics.
Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic sciences; DNA analysis services for scientific research purposes; medical and scientific research, in particular in the fields of prevention and treatment cancer; providing scientific research information, consultancy, and advisory services, in particular in the fields of prevention and treatment of cancer treatment; conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; and consulting services for others in the field of design, planning, and implementation of clinical trials; design, engineering, research, development and testing services in the field of nucleic acid sciences for medical, scientific and technological applications; scientific research; scientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics.
Class 44:
Medical services, in particular providing therapy and vaccination approaches for treating and preventing cancer, infectious diseases and immunological diseases; veterinary services, in particular providing therapy and vaccination approaches for treating and preventing cancer, infectious diseases, and immunological diseases; medical, veterinary and pharmaceutical consultation; medical and veterinary diagnostic testing, monitoring and reporting services; providing medical information, consultancy, and advisory services, in particular in the fields of treatment and prevention of immunological diseases, cancer treatment, prevention of cancer, treatment of infectious diseases, and prevention of infectious diseases; medical services, namely, providing therapies for treating cancer, medical and pharmaceutical consultation; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposes.
Medical services, in particular providing therapy and vaccination approaches for treating and preventing cancer, infectious diseases and immunological diseases; veterinary services, in particular providing therapy and vaccination approaches for treating and preventing cancer, infectious diseases, and immunological diseases; medical, veterinary and pharmaceutical consultation; medical and veterinary diagnostic testing, monitoring and reporting services; providing medical information, consultancy, and advisory services, in particular in the fields of treatment and prevention of immunological diseases, cancer treatment, prevention of cancer, treatment of infectious diseases, and prevention of infectious diseases; medical services, namely, providing therapies for treating cancer, medical and pharmaceutical consultation; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposes.